Evidence map›Paper›PMID 30677038›Full record

ArticlePLoS neglected tropical diseases2019

Estimating the association between being seropositive for cysticercosis and the prevalence of epilepsy and severe chronic headaches in 60 villages of rural Burkina Faso.

Ida Sahlu, Hélène Carabin, Rasmané Ganaba, Pierre-Marie Preux, Assana Kone Cissé, Zekiba Tarnagda, Sarah Gabriël, Veronique Dermauw, Pierre Dorny, Cici Bauer and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Modelling forBulletin of the World Health Organization · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 5 countries.

Ida SahluDepartment of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, United States of America.
Hélène CarabinDepartment of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.ORCID 0000-0002-2822-4730
Rasmané GanabaAgence de Formation de Recherche et d'Expertise en Santé pour l'Afrique (AFRICSanté), Bobo Dioulasso, Burkina Faso.
Pierre-Marie PreuxINSERM, Univ. Limoges, CHU Limoges, UMR 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, Limoges, France.
Assana Kone CisséInstitute of Research in Health Sciences, Bobo Dioulasso, Burkina Faso.
Zekiba TarnagdaInstitute of Research in Health Sciences, Bobo Dioulasso, Burkina Faso.
Sarah GabriëlDepartment of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Veronique DermauwUnit of Veterinary Helminthology, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Pierre DornyUnit of Veterinary Helminthology, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Cici BauerDepartment of Biostatistics and Data Science, University of Texas Health Science Center at Houston, Texas, United States of America.
Athanase MillogoCentre Hospitalier Universitaire Souro SANOU, Bobo-Dioulasso, Burkina Faso.
Ghent University · BEInstitut de Recherche en Sciences de la Santé · BFAFRICSanté · BFBrown University · USInserm · FRInstituut voor Tropische Geneeskunde · BENazi Boni University · BFThe University of Texas Health Science Center at Houston · USUniversity of Oklahoma Health Sciences Center · US

Funding

TRAINING IN DEMOGRAPHYT32HD007338 · NICHD · BROWN UNIVERSITY · PI ANDREW D. FOSTER · 1987 to 2026
$7.0M
EFECAB: Improving pig management to prevent epilepsy in Burkina FasoR01NS064901 · NINDS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CARABIN, HELENE · 2010 to 2014
$2.3M
Epidemiologic and spatial methods to improve estimates of neurological disorders from population based studiesF31NS093983 · NINDS · BROWN UNIVERSITY · PI SAHLU, IDA A. · 2015 to 2016
$87k
NICHD NIH HHS T32 HD007338NINDS NIH HHS F31 NS093983NINDS NIH HHS R01 NS064901
6 · The paper itself

Abstract

backgroundIndividuals diagnosed with neurocysticercosis often present with epilepsy and sometimes with progressively worsening severe chronic headaches (WSCH). While cross-sectional associations between seropositivity to cysticercal antigens and epilepsy have been reported, few large scale studies have been conducted in West Africa and none have measured the association between seropositivity to cysticercal antigens and headaches. This study aimed at filling these knowledge gaps by estimating the strength of the cross-sectional association between seropositivity to cysticercal antigens and the prevalence of epilepsy and WSCH in 60 villages of Burkina Faso, West Africa. METHODOLOGY/PRINCIPAL

findingsBaseline data from a cluster randomized controlled trial collected from January 2011 to February 2012 in 60 villages across three provinces in Burkina Faso were used. Between 78 and 80 individuals were screened for epilepsy and WSCH in each village, and those screened positive were confirmed by a physician. Seventy-five percent of all participants were asked to provide a blood sample to test for Taenia solium cysticercus circulating antigens. Hierarchical multivariable logistic models were used to measure the association between seropositivity to cysticercal antigens and epilepsy (lifetime and active) as well as WSCH. Among 3696 individuals who provided a blood sample, 145 were found to have epilepsy only, 140 WSCH only and 19 both. There were positive associations between seropositivity to cysticercal antigens and active epilepsy (prevalence odds ratio (POR): 2.40 (95%CI: 1.15-5.00)) and WSCH (POR: 2.59 (1.34-4.99)). CONCLUSIONS/SIGNIFICANCE: Our study is the first to demonstrate a cross-sectional association between seropositivity to cysticercal antigens and WSCH in a large community-based study conducted in West Africa. The measured cross-sectional association had a strength similar to the ones previously observed between seropositivity to cysticercal antigens and lifetime or active epilepsy. As a result, preventing new cysticercosis cases in communities may reduce the prevalence of these two important neurological disorders.

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsAntigens, HelminthBurkina FasoChildCross-Sectional StudiesEpilepsyFemaleHeadache DisordersHumansMaleMiddle AgedNeurocysticercosisAntigens, Helminth

Identifiers

PMID30677038
PMCPMC6345432
OpenAlexW2914634834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.